The nitric oxide-cyclic GMP pathway regulates FoxO and alters dopaminergic neuron survival in Drosophila.
Activation of the forkhead box transcription factor FoxO is suggested to be involved in dopaminergic (DA) neurodegeneration in a Drosophila model of Parkinson's disease (PD), in which a PD gene product LRRK2 activates FoxO through phosphorylation. In the current study that combines Drosophila g...
Saved in:
| Main Authors: | Tomoko Kanao, Tomoyo Sawada, Shireen-Anne Davies, Hiroshi Ichinose, Kazuko Hasegawa, Ryosuke Takahashi, Nobutaka Hattori, Yuzuru Imai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2012-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0030958&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
FoxO Proteins in the Nervous System
by: Kenneth Maiese
Published: (2015-01-01) -
Unraveling the mystery: How autophagy deficiency in dopaminergic neurons drives human Parkinson’s disease
by: Sachiko Noda, et al.
Published: (2025-07-01) -
The multifaceted impact of physical exercise on FoxO signaling pathways
by: Wei Liu, et al.
Published: (2025-08-01) -
Proteomic surveys of the mouse heart unveil cardiovascular responses to nitric oxide/cGMP signaling deficiencies
by: Ipsita Mohanty, et al.
Published: (2025-05-01) -
Regulation of Myogenesis by MechanomiR-200c/FoxO3 Axis
by: Junaith S. Mohamed, et al.
Published: (2025-06-01)